
Song Da 505 (S55) - Financial and Strategic SWOT Analysis Review
Description
Daxor Corp (DXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Daxor Corp (Daxor) is a biotechnology company, which offers original medical equipment for medical personnel. The company manufactures blood volume analyzers. Its flagship product, BVA-100 blood volume analyzer is an instrument to measure human blood volume. The product is used in conjunction with Volumex, a diagnostic radiopharmaceutical containing iodinated I 131 albumins. It finds application in a range of medical and surgical conditions which includes congestive heart failure, intensive care unit medicine, critical care medicine, syncope, kidney failure, hypertension, renal failure, red blood cell abnormalities, hyponatremia and other conditions. The company offers its product to hospitals, clinics, and physicians. Daxor is headquartered in Oak Ridge, the US.
Daxor Corp Key Recent Developments
Feb 13,2025: New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
Aug 29,2024: Daxor Corporation Announces Launch Of BVA Program At Mid-south Largest Integrated Network
Apr 15,2024: Daxor Corporation to Exhibit at the Medaxiom Cardiovascular Transforum Conference Spring’24 to Advance Awareness and Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100™)
Mar 22,2024: Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Daxor Corp (Daxor) is a biotechnology company, which offers original medical equipment for medical personnel. The company manufactures blood volume analyzers. Its flagship product, BVA-100 blood volume analyzer is an instrument to measure human blood volume. The product is used in conjunction with Volumex, a diagnostic radiopharmaceutical containing iodinated I 131 albumins. It finds application in a range of medical and surgical conditions which includes congestive heart failure, intensive care unit medicine, critical care medicine, syncope, kidney failure, hypertension, renal failure, red blood cell abnormalities, hyponatremia and other conditions. The company offers its product to hospitals, clinics, and physicians. Daxor is headquartered in Oak Ridge, the US.
Daxor Corp Key Recent Developments
Feb 13,2025: New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
Aug 29,2024: Daxor Corporation Announces Launch Of BVA Program At Mid-south Largest Integrated Network
Apr 15,2024: Daxor Corporation to Exhibit at the Medaxiom Cardiovascular Transforum Conference Spring’24 to Advance Awareness and Further Adoption of Daxor’s Blood Volume Diagnostic (BVA-100™)
Mar 22,2024: Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note:Some sections may be missing if data is unavailable for the company
Table of Contents
28 Pages
- Section 1 - About the Company
- Song Da 505 - Key Facts
- Song Da 505 - Key Employees
- Song Da 505 - Major Products and Services
- Song Da 505 - History
- Song Da 505 - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- Song Da 505 - Business Description
- Song Da 505 - SWOT Analysis
- SWOT Analysis - Overview
- Song Da 505 - Strengths
- Song Da 505 - Weaknesses
- Song Da 505 - Opportunities
- Song Da 505 - Threats
- Song Da 505 - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Song Da 505, Key Facts
- Song Da 505, Key Employees
- Song Da 505, Major Products and Services
- Song Da 505, History
- Song Da 505, Subsidiaries
- Song Da 505, Key Competitors
- Song Da 505, Ratios based on current share price
- Song Da 505, Annual Ratios
- Song Da 505, Annual Ratios (Cont...1)
- Song Da 505, Annual Ratios (Cont...2)
- Song Da 505, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Song Da 505, Performance Chart (2019 - 2023)
- Song Da 505, Ratio Charts
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.